Back
SPDR® S&P Health Care Services ETF Vs. Range Cancer Therapeutics ETF Industry Stock Comparison
Sell
46
XHS
SPDR® S&P Health Care Services ETF
Last Price:
95.60
Seasonality Move:
5.43%
Sell
44
CNCR
Range Cancer Therapeutics ETF
Last Price:
13.62
Seasonality Move:
2.72%
Sell
46
SPDR® S&P Health Care Services ETF (XHS)
is a Sell
Is SPDR® S&P Health Care Services ETF a Buy, Sell or Hold?
- The current SPDR® S&P Health Care Services ETF [XHS] share price is $94.44. The Score for XHS is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- XHS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Range Cancer Therapeutics ETF (CNCR)
is a Sell
Is Range Cancer Therapeutics ETF a Buy, Sell or Hold?
- The current Range Cancer Therapeutics ETF [CNCR] share price is $13.22. The Score for CNCR is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- CNCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
XHS Stock Price Chart
What is SPDR® S&P Health Care Services ETF's stock price today?
-
The SPDR® S&P Health Care Services ETF share price today is $94.44
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XHS is experiencing buying pressure, which is a positive indicator for future bullish movement.
CNCR Stock Price Chart
What is Range Cancer Therapeutics ETF's stock price today?
-
The Range Cancer Therapeutics ETF share price today is $13.22
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNCR is experiencing slight selling pressure.
XHS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.46 | Sell |
Relative Strength Index (14 RSI): | 49.58 | Sell |
Chaikin Money Flow: | 2685 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (92.61 - 96.33) | Sell |
Bollinger Bands (100): | (92.83 - 97.75) | Sell |
CNCR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.42 | Sell |
Relative Strength Index (14 RSI): | 30.23 | Sell |
Chaikin Money Flow: | -1460 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.96 - 15.52) | Sell |
Bollinger Bands (100): | (14.08 - 15.46) | Sell |
XHS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 93.72 | Buy |
20-day SMA: | 94.48 | Sell |
50-day SMA: | 95.16 | Sell |
200-day SMA: | 92.88 | Buy |
8-day EMA: | 93.81 | Buy |
20-day EMA: | 94.39 | Buy |
50-day EMA: | 94.85 | Sell |
200-day EMA: | 93.09 | Buy |
CNCR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.87 | Sell |
20-day SMA: | 14.66 | Sell |
50-day SMA: | 14.91 | Sell |
200-day SMA: | 15.06 | Sell |
8-day EMA: | 13.82 | Sell |
20-day EMA: | 14.4 | Sell |
50-day EMA: | 14.7 | Sell |
200-day EMA: | 14.56 | Sell |
SPDR® S&P Health Care Services ETF Earnings Growth & XHS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Range Cancer Therapeutics ETF Earnings Growth & CNCR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
SPDR® S&P Health Care Services ETF Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Range Cancer Therapeutics ETF Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |